Position in NVS
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$5,064,406
+$4,297,449 QoQ
Shares Held
32,315
+543.6% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#260
of 1,603 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 43%
Shared 0%
None 57%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Arax Advisory Partners holds $367,571,362 across 18 Drug Manufacturers - General names. NVS ranks #11 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
326,790 | $82,994,856 | |
| 2 | MRK |
Merck & Co., Inc.
|
608,608 | $78,206,128 | |
| 3 | LLY |
ELI LILLY & Co
|
46,821 | $56,158,516 | |
| 4 | ABBV |
AbbVie Inc.
|
164,897 | $41,494,681 | |
| 5 | NVO |
Novo Nordisk A S
|
449,006 | $21,525,347 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
363,882 | $20,966,880 | |
| 7 | PFE |
Pfizer Inc
|
811,104 | $19,531,384 | |
| 8 | AMGN |
Amgen Inc
|
50,310 | $18,218,257 |
All Filings in NVS
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,064,406 | 32,315 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $766,957 | 5,021 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $994,456 | 7,213 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,016,814 | 7,929 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $402,600 | 3,327 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $441,126 | 3,957 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $100,910 | 1,037 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $113,063 | 983 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $139,142 | 1,307 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $122,169 | 1,263 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $127,020 | 1,258 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $126,713 | 1,244 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $123,816 | 1,227 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $104,512 | 1,136 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $75,660 | 834 | Shares | Sole | 2023-02-24 | |
| 2022-09-30 | $73,273 | 964 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $20,540 | 243 | Shares | Sole | 2022-08-22 | |
| 2022-03-31 | $21,323 | 243 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $5,248 | 60 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $3,516 | 43 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $4,926 | 54 | Shares | Sole | 2021-08-02 | |
| No filing history on record for this holder in this stock. | ||||||